Project KT2022-11: Evaluate biodistribution of PET-labelled EV following various administration routes (2022–2023)

Grant type:
Exopharm
Researchers:
  • Senior Group Leader and Deputy Dire
    Centre for Advanced Imaging
    Australian Institute for Bioengineering and Nanotechnology
    Affiliate PRF & Group Leader
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Exopharm Limited